Health Industry Watch
SEE OTHER BRANDS

Your healthcare and wellness news reporter

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on May 5, 2025

Coherus to Report First Quarter 2025 Financial Results on May 12, 2025

Coherus to Report First Quarter 2025 Financial Results on May 12, 2025

REDWOOD CITY, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its first quarter 2025 financial results will be released after market close on Monday, May 12, 2025. Starting at 5:00 p.m. EDT …

Solésence Reports Record First Quarter 2025 Financial Results

Solésence Reports Record First Quarter 2025 Financial Results

First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today …

Xenon to Report Q1 2025 Financial Results on May 12, 2025

Xenon to Report Q1 2025 Financial Results on May 12, 2025

VANCOUVER, British Columbia and BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Syndax Reports First Quarter 2025 Financial Results and Provides Business Update

Syndax Reports First Quarter 2025 Financial Results and Provides Business Update

– $20.0 million in Revuforj® (revumenib) net revenue in first full quarter of launch – – $13.6 million in Niktimvo™ (axatilimab-csfr) net revenue (reported by Incyte) in first partial quarter of launch – – Submitted sNDA for revumenib in R/R mNPM1 AML – – …

Global Leader in Thermal Management  Laird Thermal Systems Unveils New Identity

Global Leader in Thermal Management Laird Thermal Systems Unveils New Identity

ROSENHEIM, GERMANY, May 5, 2025 /⁨EINPresswire.com⁩/ -- Laird Thermal Systems, a global leader in active thermal management solutions with more than 60 years of application expertise, today announced its rebrand to Tark Thermal Solutions. This name change …

Pcloudy Launches AI-Powered Mobile App Performance Experience Testing to Eliminate Issues and Accelerate Digital Quality

Pcloudy Launches AI-Powered Mobile App Performance Experience Testing to Eliminate Issues and Accelerate Digital Quality

Pcloudy unveils AI-driven mobile app performance testing to help engineering teams detect, diagnose, and resolve performance issues before they affect users. CA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Today, Pcloudy, a leading digital …

DrEO Clinic Named Best Hair Transplant Clinic in Mexico for 2025, Leading the Way in Affordable Medical Tourism

DrEO Clinic Named Best Hair Transplant Clinic in Mexico for 2025, Leading the Way in Affordable Medical Tourism

Mexico City, Mexico, May 05, 2025 (GLOBE NEWSWIRE) -- DrEO Clinic has been recognized as the best hair transplant clinic in Mexico for 2025, reinforcing its position at the forefront of hair restoration excellence. The announcement follows endorsements …

Global Extended Release Drugs Market Set to Reach CAGR of 11% through 2032 | FMI

Global Extended Release Drugs Market Set to Reach CAGR of 11% through 2032 | FMI

Extended Release Drugs Market sees rising demand due to improved patient compliance, steady dosing, and reduced side effects. NEWARK, DE, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- The global extended release drugs market is witnessing remarkable …

Global Small Bowel Enteroscope Market Set for Robust Growth, Expected to Surpass 8% to 9% CAGR by 2032

Global Small Bowel Enteroscope Market Set for Robust Growth, Expected to Surpass 8% to 9% CAGR by 2032

Rising GI disorders and advanced endoscopy tech fuel growth in the small bowel enteroscopes market globally. NEWARK, DE, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- The global small bowel enteroscope market is poised for a decade of strong and …

Robert Olsen Receives Individual Achievement Award from the Healthcare Financial Management Association

Robert Olsen Receives Individual Achievement Award from the Healthcare Financial Management Association

NASHVILLE, Tenn., May 05, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today presented Robert Olsen with the 2025 Frederick C. Morgan Individual Achievement Award, honoring career-long contributions to HFMA and to the …

Prostate Cancer Types Market Set for Robust Growth Through 2034, Driven by Advances in Targeted Therapies and Biomarker | DelveInsight

Prostate Cancer Types Market Set for Robust Growth Through 2034, Driven by Advances in Targeted Therapies and Biomarker | DelveInsight

New York, USA, May 05, 2025 (GLOBE NEWSWIRE) -- Prostate Cancer Types Market Set for Robust Growth Through 2034, Driven by Advances in Targeted Therapies and Biomarker | DelveInsight The prostate cancer market is expected to witness significant growth …

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

ZURICH, SWITZERLAND, May 05, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ: VACH, "Voyager"), announced today a co- …

OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab

OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab

OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab Lusvertikimab well tolerated over the 24-week additional treatment period. Oral presentation at DDW 2025 of clinical data from …

OSE Immunotherapeutics annonce que plus de 90% des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab

OSE Immunotherapeutics annonce que plus de 90% des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab

OSE Immunotherapeutics annonce que plus de 90 % des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab Bonne tolérance de Lusvertikimab pendant les 24 semaines supplémentaires de traitement. …

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell …

How individuals grasp an object may offer simpler diagnosis for autism spectrum disorder

How individuals grasp an object may offer simpler diagnosis for autism spectrum disorder

Toronto, May 05, 2025 (GLOBE NEWSWIRE) -- Getting a timely diagnosis of autism spectrum disorder is a major challenge, but new research out of York University shows that how young adults, and potentially children, grasp objects could offer a simpler way to …

AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting

AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting

PRESS RELEASE AB SCIENCE TO PRESENT NEW DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS IN TWO PRESENTATIONS AT THE 2025 ENCALS ANNUAL MEETING MASITINIB REDUCES SERUM NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS, SUGGESTING THAT IT HAS …

AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de nouvelles données issues du programme de développement clinique du masitinib dans la SLA

AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de nouvelles données issues du programme de développement clinique du masitinib dans la SLA

COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTERA LORS DE LA RÉUNION ANNUELLE DE L'ENCALS EN 2025 DE NOUVELLES DONNÉES ISSUES DU PROGRAMME DE DEVELOPPEMENT CLINIQUE DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE LE MASITINIB RÉDUIT LA CONCENTRATION SERIQUE …

Arialief Reviews (CRITICAL INVESTIGATION) What Doctors Say About Arialief's Safety And Complaints!

Arialief Reviews (CRITICAL INVESTIGATION) What Doctors Say About Arialief's Safety And Complaints!

ALBANY, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Arialief is a thoughtfully designed natural nerve pain relief supplement that can address the root issues behind various symptoms associated with neuropathy. It is backed up by solid research and combines …

Arialief Side Effects Investigated: Review the User Complaints, Top Benefits & Ingredients List Before Buy!

Arialief Side Effects Investigated: Review the User Complaints, Top Benefits & Ingredients List Before Buy!

ALBANY, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- If you’re reading this, chances are you, or someone close to you, is dealing with the frustrating, often exhausting symptoms of nerve pain. Whether it’s tingling in your feet, burning sensations in your hands, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service